StrideGuard is a ready-to-use regenerative matrix derived from equine umbilical cord tissue. It delivers biologically active support for joint function and soft tissue repair in horses exposed to high mechanical stress. No blood draw, no spinning, and no on-site processing are required.
%
ECM retention for natural joint support
x
faster fluid rebound after stress
prep time. No spinning or blood draw.
solution for joints, ligaments, and soft tissue
For cases that demand more than just temporary relief
Clinical Applications
StrideGuard is intended for use in horses experiencing joint instability, soft tissue degeneration, or post-traumatic recovery. It is most effective in performance and working horses exposed to repetitive impact or inflammation. It can be administered as a stand-alone treatment or integrated into broader care plans.
Simple to deliver, powerful in effect
Administration & Handling
StrideGuard comes pre-packaged and sterile, requiring no spinning, blood draw, or special equipment. It is administered via standard intra-articular injection technique or directly into soft tissue, depending on the condition being treated. Because the formulation is consistent from dose to dose, veterinarians can expect predictable handling and response with every application. Its stability and ease of use also make it ideal for field-based care, particularly in rural or ambulatory practices where access to lab tools may be limited.
| Specification | Details |
|---|---|
| Product Name | StrideGuard |
| Type | Regenerative Injectable Matrix |
| Source Material | Equine umbilical cord tissue (Wharton’s Jelly) |
| Use | Intra-articular and soft tissue injection |
| Sterility | Sterile, ready-to-use |
| Formulation | ECM-rich, viscoelastic regenerative fluid |
| Packaging | Single-use vial |
| Storage Requirements | Refrigerated (do not freeze) |
| Shelf Life | 12 months from manufacture date |
| Administration | Administered by licensed veterinary professional |
Regenerative function beyond symptom management
Why Choose StrideGuard
Unlike PRP and BMAC therapies, StrideGuard is not dependent on patient-derived samples, which reduces variability and speeds up the treatment process. It also offers greater regenerative potential than hyaluronic acid, which only provides lubrication without contributing to tissue remodeling.
StrideGuard combines mechanical protection with biological activity, helping horses recover faster and maintain long-term joint health.
IDEAL FOR:
- Joint lubrication and viscoelasticity
- Tissue repair and remodeling
- Reduced post-treatment inflammation
This makes StrideGuard a compelling choice for equine professionals looking for a regenerative solution that is consistent, effective, and easy to administer.
Common Topics Explained
Frequently asked questions
How is StrideGuard different from PRP or BMAC products?
StrideGuard does not require blood or bone marrow collection from the patient. It is a lab-prepared, cord-derived matrix with consistent regenerative components. This eliminates prep time and patient variability.
Can StrideGuard be used in the field?
Yes. It is fully sterile and ready to inject, making it ideal for mobile vets and in-field treatments. No special equipment is needed.
What types of conditions is StrideGuard best suited for?
StrideGuard is effective for joint and soft tissue conditions including navicular syndrome, stifle injuries, suspensory ligament strain, osteochondral defects, and post-operative support. It can also be used preventatively in performance horses.
How quickly does StrideGuard begin working?
Most horses show noticeable improvement in comfort and movement within days. Its viscoelastic properties help restore lubrication quickly, while the ECM content supports longer-term repair and remodeling.
Can it be used alongside other therapies?
Yes. StrideGuard can be integrated into multi-modal treatment plans that may include rest, anti-inflammatories, physical therapy, or other injectables. Always follow your clinic's protocols for combined use.

